Authors:
Belldegrun, A
Tso, CL
Zisman, A
Naitoh, J
Said, J
Pantuck, AJ
Hinkel, A
de Kernion, J
Figlin, R
Citation: A. Belldegrun et al., Interleukin 2 gene therapy for prostate cancer: Phase I clinical trial andbasic biology, HUM GENE TH, 12(8), 2001, pp. 883-892
Authors:
Hinkel, A
Tso, CL
Gitlitz, BJ
Neagos, N
Schmid, I
Paik, SH
deKernion, J
Figlin, R
Belldegrun, A
Citation: A. Hinkel et al., Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma, J IMMUNOTH, 23(1), 2000, pp. 83-93
Authors:
Mulders, P
Tso, CL
Gitlitz, B
Kaboo, R
Hinkel, A
Frand, S
Kiertscher, S
Roth, MD
deKernion, J
Figlin, R
Belldegrun, A
Citation: P. Mulders et al., Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: Implications for live kidney cancer vaccines, CLIN CANC R, 5(2), 1999, pp. 445-454